AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Mar 4, 2021
29821_dirs_2021-03-04_424f86b6-d0c3-45dd-af35-1993b8c56478.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-03-03
Reporting Person: Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-03 | Common Stock | M | 3603.0000 | $0.0000 | Acquired | 252559.0000 | Direct |
| 2021-03-03 | Common Stock | F | 1779.0000 | $38.8200 | Disposed | 250780.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-03 | Deferred Stock Units | $ | M | 3603.0000 | Disposed | 2022-03-03 | Common Stock (3603.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 68305.0000 | Indirect |
| Common Stock | 6038.0000 | Indirect |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3: The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant.